Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01178 (
oxytocin
)
15,767
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
CD38 encodes a ligand in the
oxytocin
signaling pathway. Some single nucleotide polymorphisms in this gene have been associated with low serum
oxytocin
levels in autism spectrum disorder (ASD) patients.
Oxytocin
disruption has been hypothesized to account for features of ASD, including impaired communication and social behavior, based on animal studies. Recent human studies have shown administration of
oxytocin
improving emotion recognition, promoting social behavior, and improving auditory processing of social stimuli in ASD patients. In addition to its role in
oxytocin
signaling, CD38 is involved in the regulation of calcium concentration in airway smooth muscle with impairment of CD38 being implicated in airway diseases like asthma. While a number of studies have implicated rare chromosomal deletions and duplications in helping determine genetic risk for autism, there are to our knowledge no reports describing rearrangements involving CD38 or deletions in patients with ASD. Here, we present two sisters diagnosed with autism and with features of regression-previously acquired speech lost in the second year of life. The younger sister, who also had asthma, inherited a maternal deletion of 4p15.32 that results in a
BST1
-CD38 fusion transcript. Their mother's deletion was mosaic and she was not affected. Although further work is required to assess functional consequences of the fusion transcript, we hypothesize that the proband's deletion may have served as a risk factor for autism that, when combined with other susceptibility variants, resulted in a more severe presentation than her sister.
...
PMID:A deletion involving CD38 and BST1 results in a fusion transcript in a patient with autism and asthma. 2463 87
Communication consists of social interaction, recognition, and information transmission. Communication ability is the most affected component in children with autism spectrum disorder (ASD). Recently, we reported that the
CD157/
BST1
gene is associated with ASD, and that CD157 knockout (
Cd157
-/-
) mice display severe impairments in social behavior that are improved by
oxytocin
(
OXT
) treatment. Here, we sought to determine whether
Cd157
-/-
mice can be used as a suitable model for communication deficits by measuring ultrasonic vocalizations (USVs), especially in the early developmental stage. Call number produced in pups due to isolation from dams was higher at postnatal day (PND) 3 in knockout pups than wild-type mice, but was lower at PNDs 7 and 10. Pups of both genotypes had similarly limited voice repertoires at PND 3. Later on, at PNDs 7 and 10, while wild-type pups emitted USVs consisting of six different syllable types, knockout pups vocalized with only two types. This developmental impairment in USV emission was rescued within 30 min by intraperitoneal
OXT
treatment, but quickly returned to control levels after 120 min, showing a transient effect of
OXT
. USV impairment was partially observed in
Cd157
+/-
heterozygous mice, but not in
Cd157
-/-
adult male mice examined while under courtship. These results demonstrate that
CD157
gene deletion results in social communication insufficiencies, and suggests that CD157 is likely involved in acoustic communication. This unique
OXT
-sensitive developmental delay in
Cd157
-/-
pups may be a useful model of communicative interaction impairment in ASD.
...
PMID:Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of
Cd157
Knockout Mice: Transient Improvement by Oxytocin. 2856 99
Recent studies provide evidence to support that cluster of differentiation 38 (CD38) and CD157 meaningfully act in the brain as neuroregulators. They primarily affect social behaviors. Social behaviors are impaired in
Cd38
and
Cd157
knockout mice. Single-nucleotide polymorphisms of the
CD38
and CD157/
BST1
genes are associated with multiple neurological and psychiatric conditions, including autism spectrum disorder, Parkinson's disease, and schizophrenia. In addition, both antigens are related to infectious and immunoregulational processes. The most important clues to demonstrate how these molecules play a role in the brain are
oxytocin
(OT) and the OT system. OT is axo-dendritically secreted into the brain from OT-containing neurons and causes activation of OT receptors mainly on hypothalamic neurons. Here, we overview the CD38/CD157-dependent OT release mechanism as the initiation step for social behavior. The receptor for advanced glycation end-products (RAGE) is a newly identified molecule as an OT binding protein and serves as a transporter of OT to the brain, crossing over the blood-brain barrier, resulting in the regulation of brain OT levels. We point out new roles of CD38 and CD157 during neuronal development and aging in relation to nicotinamide adenine dinucleotide
+
levels in embryonic and adult nervous systems. Finally, we discuss how CD38, CD157, and RAGE are crucial for social recognition and behavior in daily life.
...
PMID:CD38, CD157, and RAGE as Molecular Determinants for Social Behavior. 3188 55